封面
市場調查報告書
商品編碼
1513570

透析機市場 - 按產品類型(血液透析機、腹膜透析機)、最終用途(中心透析、家庭中心透析)全球預測(2024 - 2032)

Dialysis Machines Market - By Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines), By End-use (In-center Dialysis, Home center dialysis) Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 89 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於透析機的技術突破、提高效率和病患舒適度以及全球政府積極主動的舉措,2024年至2032年全球透析機市場規模將累積4.3%的複合年成長率。攜帶式和家庭解決方案等創新滿足了患者對便利腎臟護理選擇不斷成長的需求。政府透過醫療改革和資金提供的支持進一步提高了可近性和負擔能力,擴大了市場範圍。這些因素共同為日益強大的透析機產業鋪平了道路,解決了全球慢性腎臟病日益流行的問題。

例如,2023 年 9 月,KUTRRH 引進了肯亞政府購買的 20 台透析機,這對於複製腎臟功能至關重要。這些設備改變了腎臟護理,使許多患者在腎臟面臨挑戰的情況下仍能維持生活品質。這一發展顯示人們越來越致力於改善醫療基礎設施和滿足腎臟病患者的需求。它也反映出全球對透析機的需求可能會增加,這是由旨在提高腎臟病患者的治療可及性和生活品質的類似舉措所推動的。

透析機市場根據產品類型、最終用途和地區進行分類。

到 2032 年,腹膜透析機細分市場將在可及性、成本效益和患者對家庭治療偏好等方面的優勢推動下,獲得顯著的市場佔有率。與需要專門中心的血液透析不同,腹膜透析可以在家中進行,提供更大的便利性並減少醫療支出。這些機器有助於持續治療,確保定期清除體內毒素,而無需頻繁去醫院。隨著醫療保健系統專注於擴大家庭醫療保健選擇,腹膜透析機的採用率和市場將持續成長。

由於對以病人為中心的照護選擇的需求不斷成長,到 2032 年,家庭透析細分市場將建立穩固的立足點。科技的進步使居家透析變得更加容易和高效,使患者能夠方便地管理治療。降低醫療成本、改善治療結果和更大的患者自主權等因素促進了該細分市場的成長。這一趨勢凸顯了向個人化醫療保健解決方案的轉變,使慢性腎臟病患者能夠維持生活品質,同時在舒適的家中管理自己的病情。

到 2032 年,亞太地區透析機產業佔有率將實現顯著的複合年成長率,這歸因於醫療保健支出的增加、腎臟疾病盛行率的增加以及醫療保健設施的普及。中國和印度等國家正在見證先進醫療技術的快速採用,而政府改善醫療基礎設施的舉措進一步推動了市場成長。此外,人們對腎臟疾病的認知不斷提高,農村地區醫療保健服務的改善也使該地區成為全球透析機市場的重要貢獻者。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 末期腎病 (ESRD) 患者數量不斷增加
      • 糖尿病發生率增加
      • 供腎短缺
      • 透析治療可獲得有利的報銷方案
      • 已開發國家及開發中國家的研發投資
    • 產業陷阱與挑戰
      • 產品召回
      • 治療中的併發症
  • 成長潛力分析
  • 居家透析景觀
  • 監管環境
  • 報銷場景
  • 價值鏈分析
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2021 - 2032

  • 主要趨勢
  • 血液透析機
  • 腹膜透析機

第 6 章:市場估計與預測:依最終用途,2021 - 2032 年

  • 主要趨勢
  • 中心透析
  • 居家透析中心

第 7 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章:公司簡介

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dialife SA
  • Fresenius SE & Co. KGaA
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Inc.
  • Toray Medical Co., Ltd.
簡介目錄
Product Code: 9059

Global Dialysis Machines Market size will accumulate a 4.3% CAGR from 2024 to 2032, owing to technological breakthroughs in dialysis machines, enhancing efficiency and patient comfort, in line with proactive government initiatives globally. Innovations such as portable and home-based solutions cater to rising patient demand for convenient renal care options. Government support through healthcare reforms and funding further boosts accessibility and affordability, expanding the market reach. These factors collectively pave the way for an increasingly robust dialysis machines industry, addressing the growing prevalence of chronic kidney diseases worldwide.

For instance, in September 2023, KUTRRH introduced 20 dialysis machines purchased by the Kenyan government, crucial in replicating kidney functions. These devices have transformed renal care, allowing many patients to maintain quality of life despite kidney challenges. This development suggests a growing commitment to improving healthcare infrastructure and addressing the needs of patients with kidney diseases. It also reflects a potential increase in demand for dialysis machines globally, driven by similar initiatives aimed at enhancing treatment accessibility and quality of life for patients suffering from renal conditions.

The dialysis machines market is classified based on product type, end-use, and region.

The peritoneal dialysis machines segment will garner noteworthy market share by 2032, propelled by its advantages in accessibility, cost-effectiveness, and patient preference for home-based treatments. Unlike hemodialysis, which requires specialized centers, peritoneal dialysis can be performed at home, offering greater convenience and reducing healthcare expenditures. These machines facilitate continuous treatment, ensuring regular toxin removal from the body without the need for frequent hospital visits. As healthcare systems focus on expanding home healthcare options, peritoneal dialysis machines will see increased adoption and market growth.

The home dialysis segment will establish a substantial foothold by 2032 due to rising demand for patient-centric care options. Advancements in technology have made home dialysis more accessible and efficient, allowing patients to manage treatments conveniently. Factors such as reduced healthcare costs, improved treatment outcomes, and greater patient autonomy contribute to the segment's growth. This trend underscores a shift towards personalized healthcare solutions, empowering patients with chronic kidney diseases to maintain their quality of life while managing their condition from the comfort of home.

Asia Pacific dialysis machines industry share will register a notable CAGR through 2032, attributed to increasing healthcare expenditure, the growing prevalence of renal disorders, and expanding access to healthcare facilities. Countries like China and India are witnessing rapid adoption of advanced medical technologies, while government initiatives to improve healthcare infrastructure further drive market growth. Additionally, rising awareness about kidney diseases and improving healthcare access in rural areas contribute to the region's prominence as a significant contributor to the global dialysis machines market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Increasing incidence of diabetes
      • 3.2.1.3 Shortage of donor kidneys
      • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
      • 3.2.1.5 R&D investments in developed as well as developing countries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Product recalls
      • 3.2.2.2 Complication in the treatment
  • 3.3 Growth potential analysis
  • 3.4 Home dialysis landscape
  • 3.5 Dialysis market, 2021 -2032
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Value chain analysis
  • 3.9 Technological landscape
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
  • 5.3 Peritoneal dialysis machines

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 In-center dialysis
  • 6.3 Home center dialysis

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
  • 8.2 Baxter International Inc.
  • 8.3 Dialife SA
  • 8.4 Fresenius SE & Co. KGaA
  • 8.5 JMS Co., Ltd.
  • 8.6 Medtronic plc
  • 8.7 Nikkiso Co Ltd.
  • 8.8 Nipro Corporation
  • 8.9 Outset Medical, Inc.
  • 8.10 Quanta Dialysis Technologies Inc.
  • 8.11 Toray Medical Co., Ltd.